These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21782458)

  • 41. Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends.
    Fabini E; Manoni E; Ferroni C; Rio AD; Bartolini M
    Future Med Chem; 2019 Apr; 11(8):901-921. PubMed ID: 30998113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequence specificity and role of proximal amino acids of the histone H3 tail on catalysis of murine G9A lysine 9 histone H3 methyltransferase.
    Chin HG; Pradhan M; Estève PO; Patnaik D; Evans TC; Pradhan S
    Biochemistry; 2005 Oct; 44(39):12998-3006. PubMed ID: 16185068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase.
    Dhayalan A; Kudithipudi S; Rathert P; Jeltsch A
    Chem Biol; 2011 Jan; 18(1):111-20. PubMed ID: 21276944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A fluorescence-based supramolecular tandem assay for monitoring lysine methyltransferase activity in homogeneous solution.
    Florea M; Kudithipudi S; Rei A; González-Álvarez MJ; Jeltsch A; Nau WM
    Chemistry; 2012 Mar; 18(12):3521-8. PubMed ID: 22367964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of substrates for a SET domain lysine methyltransferase predicted by multistate computational protein design.
    Lanouette S; Davey JA; Elisma F; Ning Z; Figeys D; Chica RA; Couture JF
    Structure; 2015 Jan; 23(1):206-215. PubMed ID: 25533488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity.
    Ng SS; Kavanagh KL; McDonough MA; Butler D; Pilka ES; Lienard BM; Bray JE; Savitsky P; Gileadi O; von Delft F; Rose NR; Offer J; Scheinost JC; Borowski T; Sundstrom M; Schofield CJ; Oppermann U
    Nature; 2007 Jul; 448(7149):87-91. PubMed ID: 17589501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
    Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
    J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural basis for the specific recognition of methylated histone H3 lysine 4 by the WD-40 protein WDR5.
    Han Z; Guo L; Wang H; Shen Y; Deng XW; Chai J
    Mol Cell; 2006 Apr; 22(1):137-44. PubMed ID: 16600877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structure of glycine N-methyltransferase from rat liver.
    Fu Z; Hu Y; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
    Biochemistry; 1996 Sep; 35(37):11985-93. PubMed ID: 8810903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT.
    Trievel RC; Flynn EM; Houtz RL; Hurley JH
    Nat Struct Biol; 2003 Jul; 10(7):545-52. PubMed ID: 12819771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases.
    Padilla A; Manganaro JF; Huesgen L; Roess DA; Brown MA; Crans DC
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space.
    Dhorma LP; Teli MK; Nangunuri BG; Venkanna A; Ragam R; Maturi A; Mirzaei A; Vo DK; Maeng HJ; Kim MH
    Eur J Med Chem; 2022 Jan; 227():113880. PubMed ID: 34656041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural chemistry of the histone methyltransferases cofactor binding site.
    Campagna-Slater V; Mok MW; Nguyen KT; Feher M; Najmanovich R; Schapira M
    J Chem Inf Model; 2011 Mar; 51(3):612-23. PubMed ID: 21366357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.
    Reynoird N; Mazur PK; Stellfeld T; Flores NM; Lofgren SM; Carlson SM; Brambilla E; Hainaut P; Kaznowska EB; Arrowsmith CH; Khatri P; Stresemann C; Gozani O; Sage J
    Genes Dev; 2016 Apr; 30(7):772-85. PubMed ID: 26988419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification of Histone Lysine Methyltransferase SMYD2 and Co-Crystallization with a Target Peptide from Estrogen Receptor α.
    Jiang Y; Holcomb J; Spellmon N; Yang Z
    Methods Mol Biol; 2016; 1366():207-217. PubMed ID: 26585137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications.
    Rubio-Tomás T
    Mol Biol Rep; 2021 Nov; 48(11):7499-7508. PubMed ID: 34510321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases.
    Guitot K; Drujon T; Burlina F; Sagan S; Beaupierre S; Pamlard O; Dodd RH; Guillou C; Bolbach G; Sachon E; Guianvarc'h D
    Anal Bioanal Chem; 2017 Jun; 409(15):3767-3777. PubMed ID: 28389916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase.
    Yang S; Zheng X; Lu C; Li GM; Allis CD; Li H
    Genes Dev; 2016 Jul; 30(14):1611-6. PubMed ID: 27474439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.
    Meng F; Cheng S; Ding H; Liu S; Liu Y; Zhu K; Chen S; Lu J; Xie Y; Li L; Liu R; Shi Z; Zhou Y; Liu YC; Zheng M; Jiang H; Lu W; Liu H; Luo C
    J Med Chem; 2015 Oct; 58(20):8166-81. PubMed ID: 26390175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation of the retinoblastoma tumor suppressor by SMYD2.
    Saddic LA; West LE; Aslanian A; Yates JR; Rubin SM; Gozani O; Sage J
    J Biol Chem; 2010 Nov; 285(48):37733-40. PubMed ID: 20870719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.